Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Cardiol Rep. 2013 Dec;15(12):425. doi: 10.1007/s11886-013-0425-8.

Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

Author information

  • 1.
  • 2Massachusetts General Hospital, Stroke Service, 175 Cambridge Street #300, Boston, MA 02114, USA edip@mail.harvard.edu

Abstract

Intracerebral hemorrhage (ICH, or macrobleeds) and cerebral microbleeds-smaller foci of hemosiderin deposits commonly detected by magnetic resonance imaging of older adults with or without ICH-are both associated with an increased risk of future ICH. These hemorrhagic pathologies also share risk factors with ischemic thromboembolic conditions that may require antithrombotic therapy, requiring specialists in cardiology, internal medicine, and neurology to weigh the benefits vs hemorrhagic risks of antithrombotics in individual patients. This paper will review recent advances in our understanding of hemorrhage prone cerebrovascular pathologies with a particular emphasis on use of these markers in decision making for antithrombotic use.

PMID:
24122195
[PubMed - indexed for MEDLINE]
PMCID:
PMC3965371
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk